Novartis Indian Patent Challenge Sent To Appeals Board (Forbes)

The rejection of a patent application for its Glivec cancer drug will be taken up by body set up two days ago.

Read more detail on Legal News Directory – Intellectual Property

This entry was posted in Intellectual Property and tagged , , , , , , , . Bookmark the permalink.

Leave a Reply